Dear Colleagues

I need a bit of help.

I have just received a note from one of our chemist/researchers on campus as
follows:

**************************************************************************
Mary,
 We have submitted a compound for testing at National Cancer Institute (it
is a novel compound).  They will test against approximately 60 diseases
(from cancers to Alzheimer's) in test tubes.  The first step.   Tom

Dear Prof
Thank you for registering to submit compounds through our online submission
application.
Your USERNAME is :
Your password is :
User Names and passwords are case sensitive.
The next step is for you to enroll for and install a digital site
certificate which will protect the security of your transmitted information.
Be sure to enter the DTP, NCI assigned USERNAME above when applying for your
certificate.

You must install the certificate on a browser that uses 128-bit encryption.
Minimum browser requirement:
 Internet Explorer v4.0 sp2 Netscape v4.6 Mozilla 1.4 or greater.

See:  http://dtp.nci.nih.gov/dtpcacertenrollinstructions/enroll.html

Once you have installed the certificate you may begin providing the
structures of compounds you would like to have tested.
If you have any questions, please do not hesitate to contact us.
Sincerely,
Project Manager
Contractor, NCI Chemotherapeutic Agents Repository Fisher BioServices

***************************************************************************

What should be the role of the Intellectual Property Committee in this - is
there a role?  I am at a loss as to what to do - if anything!

Your guidance will be greatly appreciated.  You can respond directly to me
if you so choose at xxxxxx@valdosta.edu.  Thanks.

Mary

Mary H. Watson, Ph.D
Director
Grants and Contracts
Valdosta State University
Valdosta, Georgia  31698

Phone:  229-333-7837
FAX:    229-245-3853
E-Mail:  xxxxxx@valdosta.edu
Web:  www.valdosta.edu/grants

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================